Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Formate reduces cardiac ischemia-reperfusion injury in murine ex vivo and in vitro models.
Journal: American journal of physiology. Heart and circulatory physiology
Published: August 25, 2026
Formate reduces ischemic injury in the male heart by increasing protein S -nitrosation.
Journal: bioRxiv : the preprint server for biology
Published: May 13, 2026
Evaluation of therapeutic radiographer target volume contouring for magnetic resonance image guided online adaptive bladder radiotherapy.
Journal: Clinical and translational radiation oncology
Published: March 26, 2025
Declining nitric oxide bioavailability in cardiovascular aging: mechanistic insights and emerging interventions.
Journal: The journal of cardiovascular aging
Published: January 01, 2025
Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial.
Journal: International journal of radiation oncology, biology, physics
Published: December 15, 2024
Stereotactic Body Radiotherapy for Oligoprogression in Castration-Resistant Prostate Cancer: Early Toxicity Analysis of the TRAP Trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 15, 2024
Pediatric Dentists' and Guardians' Perceptions of Follow-Up Appointments After Dental Rehabilitation Under General Anesthesia.
Journal: Journal of dentistry for children (Chicago, Ill.)
Published: August 25, 2023
Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI.
Journal: Technical innovations & patient support in radiation oncology
Published: September 14, 2022
Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 24, 2022
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical Practice.
Journal: Frontiers in oncology
Published: January 26, 2022
Beyond chemoradiotherapy: improving treatment outcomes for patients with stage III unresectable non-small-cell lung cancer through immuno-oncology and durvalumab (Imfinzi®▼, AstraZeneca UK Limited).
Journal: British journal of cancer
Published: December 09, 2020
Last Updated: 09/26/2026